SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

New generation VMAT2 inhibitors induced parkinsonism.

Clin Park Relat Disord · 2020-11-07

DOI: 10.1016/j.prdoa.2020.100078PMID: 34316656

Open accessletter; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

•Drug induced parkinsonism caused by valbenazine and deutetrabenazine.•Possible side effects of VMAT-2 inhibitors.•Valbenazine and deutetrabenazine can unmask underlying Parkinson's Disease.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.